Literature DB >> 20400516

DNA binding by the ETS protein TEL (ETV6) is regulated by autoinhibition and self-association.

Sean M Green1, H Jerome Coyne, Lawrence P McIntosh, Barbara J Graves.   

Abstract

The ETS protein TEL, a transcriptional repressor, contains a PNT domain that, as an isolated fragment in vitro, self-associates to form a head-to-tail polymer. How such polymerization might affect the DNA-binding properties of full-length TEL is unclear. Here we report that monomeric TEL binds to a consensus ETS site with unusually low affinity (K(d) = 2.8 x 10(-8) M). A deletion analysis demonstrated that the low affinity was caused by a C-terminal inhibitory domain (CID) that attenuates DNA binding by approximately 10-fold. An NMR spectroscopically derived structure of a TEL fragment, deposited in the Protein Data Bank, revealed that the CID consists of two alpha-helices, one of which appears to block the DNA binding surface of the TEL ETS domain. Based on this structure, we substituted two conserved glutamic acids (Glu-431 and Glu-434) with alanines and found that this activated DNA binding and enhanced trypsin sensitivity in the CID. We propose that TEL displays a conformational equilibrium between inhibited and activated states and that electrostatic interactions involving these negatively charged residues play a role in stabilizing the inhibited conformation. Using a TEL dimer as a model polymer, we show that self-association facilitates cooperative binding to DNA. Cooperativity was observed on DNA duplexes containing tandem consensus ETS sites at variable spacing and orientations, suggesting flexibility in the region of TEL linking its self-associating PNT domain and DNA-binding ETS domain. We speculate that TEL compensates for the low affinity, which is caused by autoinhibition, by binding to DNA as a cooperative polymer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20400516      PMCID: PMC2881775          DOI: 10.1074/jbc.M109.096958

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  56 in total

1.  DNA binding specificity studies of four ETS proteins support an indirect read-out mechanism of protein-DNA recognition.

Authors:  B R Szymczyna; C H Arrowsmith
Journal:  J Biol Chem       Date:  2000-09-15       Impact factor: 5.157

2.  The PEA3 Ets transcription factor comprises multiple domains that regulate transactivation and DNA binding.

Authors:  B B Bojović; J A Hassell
Journal:  J Biol Chem       Date:  2000-11-28       Impact factor: 5.157

3.  Polymerization of the SAM domain of TEL in leukemogenesis and transcriptional repression.

Authors:  C A Kim; M L Phillips; W Kim; M Gingery; H H Tran; M A Robinson; S Faham; J U Bowie
Journal:  EMBO J       Date:  2001-08-01       Impact factor: 11.598

4.  Auto-inhibition and partner proteins, core-binding factor beta (CBFbeta) and Ets-1, modulate DNA binding by CBFalpha2 (AML1).

Authors:  T L Gu; T L Goetz; B J Graves; N A Speck
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

5.  TEL contacts multiple co-repressors and specifically associates with histone deacetylase-3.

Authors:  L Wang; S W Hiebert
Journal:  Oncogene       Date:  2001-06-21       Impact factor: 9.867

6.  Structure of the elk-1-DNA complex reveals how DNA-distal residues affect ETS domain recognition of DNA.

Authors:  Y Mo; B Vaessen; K Johnston; R Marmorstein
Journal:  Nat Struct Biol       Date:  2000-04

7.  The leukemia-associated gene TEL encodes a transcription repressor which associates with SMRT and mSin3A.

Authors:  S R Chakrabarti; G Nucifora
Journal:  Biochem Biophys Res Commun       Date:  1999-11-02       Impact factor: 3.575

8.  TEL, a putative tumor suppressor, modulates cell growth and cell morphology of ras-transformed cells while repressing the transcription of stromelysin-1.

Authors:  R Fenrick; L Wang; J Nip; J M Amann; R J Rooney; J Walker-Daniels; H C Crawford; D L Hulboy; M S Kinch; L M Matrisian; S W Hiebert
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

9.  Characterization of a novel ETS gene, TELB, encoding a protein structurally and functionally related to TEL.

Authors:  H Poirel; R G Lopez; V Lacronique; V Della Valle; M Mauchauffé; R Berger; J Ghysdael; O A Bernard
Journal:  Oncogene       Date:  2000-09-28       Impact factor: 9.867

10.  Identification of a new site of sumoylation on Tel (ETV6) uncovers a PIAS-dependent mode of regulating Tel function.

Authors:  M Guy Roukens; Mariam Alloul-Ramdhani; Alfred C O Vertegaal; Zeinab Anvarian; Crina I A Balog; André M Deelder; Paul J Hensbergen; David A Baker
Journal:  Mol Cell Biol       Date:  2008-01-22       Impact factor: 4.272

View more
  37 in total

Review 1.  ETV6 in hematopoiesis and leukemia predisposition.

Authors:  Hanno Hock; Akiko Shimamura
Journal:  Semin Hematol       Date:  2017-04-07       Impact factor: 3.851

2.  Region-specific regulation of 5-HT1A receptor expression by Pet-1-dependent mechanisms in vivo.

Authors:  Kirsten X Jacobsen; Margaret Czesak; Mariam Deria; Brice Le François; Paul R Albert
Journal:  J Neurochem       Date:  2011-01-24       Impact factor: 5.372

Review 3.  Genetic defects in hematopoietic transcription factors and predisposition to acute lymphoblastic leukemia.

Authors:  Yoshihiro Gocho; Jun J Yang
Journal:  Blood       Date:  2019-07-16       Impact factor: 22.113

4.  Probing the electrostatics and pharmacological modulation of sequence-specific binding by the DNA-binding domain of the ETS family transcription factor PU.1: a binding affinity and kinetics investigation.

Authors:  Manoj Munde; Gregory M K Poon; W David Wilson
Journal:  J Mol Biol       Date:  2013-02-14       Impact factor: 5.469

5.  DNA Occupancy of Polymerizing Transcription Factors: A Chemical Model of the ETS Family Factor Yan.

Authors:  C Matthew Hope; Ilaria Rebay; John Reinitz
Journal:  Biophys J       Date:  2017-01-10       Impact factor: 4.033

6.  Autoinhibition of ETV6 DNA Binding Is Established by the Stability of Its Inhibitory Helix.

Authors:  Soumya De; Mark Okon; Barbara J Graves; Lawrence P McIntosh
Journal:  J Mol Biol       Date:  2016-02-23       Impact factor: 5.469

7.  Mechanistic heterogeneity in site recognition by the structurally homologous DNA-binding domains of the ETS family transcription factors Ets-1 and PU.1.

Authors:  Shuo Wang; Miles H Linde; Manoj Munde; Victor D Carvalho; W David Wilson; Gregory M K Poon
Journal:  J Biol Chem       Date:  2014-06-21       Impact factor: 5.157

8.  Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy.

Authors:  Michael Y Zhang; Jane E Churpek; Siobán B Keel; Tom Walsh; Ming K Lee; Keith R Loeb; Suleyman Gulsuner; Colin C Pritchard; Marilyn Sanchez-Bonilla; Jeffrey J Delrow; Ryan S Basom; Melissa Forouhar; Boglarka Gyurkocza; Bradford S Schwartz; Barbara Neistadt; Rafael Marquez; Christopher J Mariani; Scott A Coats; Inga Hofmann; R Coleman Lindsley; David A Williams; Janis L Abkowitz; Marshall S Horwitz; Mary-Claire King; Lucy A Godley; Akiko Shimamura
Journal:  Nat Genet       Date:  2015-01-12       Impact factor: 38.330

Review 9.  The oncogene ERG: a key factor in prostate cancer.

Authors:  P Adamo; M R Ladomery
Journal:  Oncogene       Date:  2015-04-27       Impact factor: 9.867

Review 10.  Transcription factor mutations as a cause of familial myeloid neoplasms.

Authors:  Jane E Churpek; Emery H Bresnick
Journal:  J Clin Invest       Date:  2019-02-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.